OAC
BDTX icon

OMERS Administration Corp’s Black Diamond Therapeutics BDTX Stock Holding History

OMERS Administration Corp’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$134K Sell
62,800
-76,100
-55% -$181K ﹤0.01% 976
2025
Q4 		$338K Buy
138,900
+127,900
+1,163% +$453K ﹤0.01% 783
2025
Q3 		$41.7K Buy
+11,000
New +$32.2K ﹤0.01% 1102
2024
Q2 		– Sell
-21,200
Closed -$107K – 1055
2024
Q1 		$107K Buy
+21,200
New +$85.5K ﹤0.01% 320

Other funds holding BDTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

OMERS Administration Corp's BDTX Position: Q1 2026 in Review

OMERS Administration Corp reduced its Black Diamond Therapeutics (BDTX) stake by 55% in Q1 2026, selling an estimated $181K and leaving 62,800 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #976.

OMERS Administration Corp first reported a position in BDTX in Q1 2024 and has held it in 4 quarters since. The position peaked at $338K in Q4 2025. 104 funds tracked by Wall St. Rank hold BDTX as of Q1 2026.

  • OMERS Administration Corp held 62,800 shares of Black Diamond Therapeutics worth $134K as of Q1 2026.
  • OMERS Administration Corp sold 76,100 Black Diamond Therapeutics shares in Q1 2026, an estimated $181K.
  • Black Diamond Therapeutics made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #976 holding.
  • OMERS Administration Corp first reported a position in Black Diamond Therapeutics in Q1 2024 and has held it in 4 quarters since.
  • OMERS Administration Corp's Black Diamond Therapeutics position peaked at $338K in Q4 2025.
  • 104 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.